Biden’s Center for Medicare and Medicaid Services extends coverage by making nonsense of the law.

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

As with any prescription medication, there are side effects of Wegovy to keep in mind. The most common side effects are ...

For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

11月18日，丹麦大型制药企业诺和诺德（NovoNordisk）发布消息称，已开始在中国销售减肥药物“Wegovy”。受肥胖困扰的人呈现增加趋势的中国一直被视为减肥药物的潜力市场。与减肥药率先普及的美国市场相比，诺和诺德预计将以较低的价格来开拓当地需 ...

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.